U.S. researchers say even if an HIV vaccine doesn't offer perfect protection against the virus, it might provide a survival advantage after infection. Such a survival advantage was observed in two monkey studies sponsored by the National Institute of Allergy and Infectious Diseases. United Press International (http://www.upi.com/NewsTrack/view.php?StoryID=20060612-013908-5699r)